San Diego-centered Viking Therapeutics marked itself as a significant competitor from the weight loss drug current market in February just after revealing promising details from a mid-stage demo of experimental drug VK2735, which prompt it rivaled—and outperformed—Novo and Lilly drugs when given as being a weekly injection As well as in March t